Androgenic Profile Following Controlled Ovarian Stimulation
Status:
Unknown status
Trial end date:
2020-01-01
Target enrollment:
Participant gender:
Summary
In this study the investigators will try to discover whether there is a difference for any of
the stimulation preparations - recombinant FSH + recombinant LH (pergoveris & luveris) vs.
human menopausal gonadotropin (menopur) during GnRH-antagonist cycles in the meaning of
androgenic hormones profile. The study question is whether using recombinant LH will result
in different follicular hormonal milieu, serum endocrine profile or IVF outcomes than using
highly purified urinary gonadotropins with hCG mimicking LH activity.